Phase I study of SAR444245 (SAR'245) as monotherapy (mono) and combined with pembrolizumab (pembro) or cetuximab (cetux) in patients (pts) with advanced solid tumors

G. S. Falchook, S. Fu, C. Lemech, M. A. Mckean, A. A. Azad, H. K. Gan, D. Sommerhalder, J. S. Wang, Tiak Ju Y. Tan, C. E. Chee, M. Barve, J. Moser, J. Mooney, N. Acuff, R. Wang, N. Marina, G. Abbadessa, M. Streit, S. Ramusovic, T. Meniawy

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S885-S886
Number of pages2
JournalAnnals of Oncology
Issue number7
Publication statusPublished - 13 Sept 2022
Event2022 Annual Meeting of the European-Society-for-Medical-Oncology - , France
Duration: 9 Sept 202213 Sept 2022

Cite this